Peter Osterbauer
Neurology · Eagle River, AKNPI 1831115955
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Livanova USA, Inc. at 41.5% of the total. Reporting peaked in 2024 at $3,180 and has fallen 70.8% since, to $927 in 2025.
Across 212 payments — averaging $57.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$5K
- Biogen$2K
- EMD Serono, Inc.$677
- Neurocrine Biosciences, Inc.$552
- AbbVie$513
- AstraZeneca$268
- plus $3K from 32 others
What the payments were for
- Consulting fees$2,04017%
- Speaking & faculty fees$110%
- Travel & lodging$4,06633%
- Food & beverage$5,97449%
- Education$1601%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 17 | $5,082 |
| Biogen | 23 | $2,279 |
| EMD Serono, Inc. | 16 | $677 |
| Neurocrine Biosciences, Inc. | 17 | $552 |
| AbbVie(2 entities) | 21 | $513 |
| AstraZeneca(2 entities) | 13 | $268 |
| Teva Pharmaceuticals USA, Inc. | 3 | $256 |
| Jazz Pharmaceuticals Inc. | 8 | $250 |
| Neurelis, Inc. | 10 | $197 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $173 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $143 |
| Argenx US, Inc. | 4 | $141 |
| UCB, Inc. | 6 | $139 |
| Amgen(2 entities) | 6 | $126 |
| Tanabe Pharma America, Inc. | 5 | $118 |
| Sanofi | 6 | $115 |
| Lundbeck LLC | 5 | $111 |
| Acorda Therapeutics, Inc | 2 | $108 |
| Sunovion Pharmaceuticals Inc. | 5 | $107 |
| E.r. Squibb & Sons, L.L.C. | 1 | $93 |
| Pfizer | 5 | $83 |
| Lilly USA, LLC | 4 | $80 |
| SK Life Science, Inc. | 3 | $75 |
| TG Therapeutics, Inc. | 3 | $74 |
| Harmony Biosciences LLC | 2 | $66 |
| Biohaven Pharmaceuticals, Inc. | 4 | $66 |
| Genentech USA, Inc. | 3 | $62 |
| Novartis | 3 | $53 |
| Bristol Myers Squibb | 2 | $41 |
| GE HealthCare | 2 | $37 |
| Eisai Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Cala Health, Inc. | 1 | $26 |
| Sarepta Therapeutics, Inc. | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Zogenix Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$4,677
- TYSABRI$1,890
- INGREZZA$265
- LUMRYZ$150
- AJOVY$125
- Mavenclad$125
- UBRELVY$124
- AUSTEDO$122
- NURTEC ODT$122
- Rebif$102
How this compares
$12,251 in reported general payments places this provider in the 80th percentile of 21 neurology providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 102 | $442,835 |
| ProgesteroneProgesterone, Micronized | 41 | $1,786 |
| Np ThyroidThyroid,pork | 25 | $1,526 |
| Levetiracetam | 27 | $1,443 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 18 | $1,258 |
| Testosterone Cypionate | 11 | $678 |
| Gabapentin | 26 | $408 |
| Nortriptyline Hcl | 11 | $149 |
| Ketorolac Tromethamine | 30 | $148 |
| Topiramate | 13 | $117 |
| Sodium Chloride0.9 % Sodium Chloride | 42 | $86 |
| Paroxetine Hcl | 12 | $85 |
| Donepezil Hcl | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other neurology in Eagle River
- Kristen JessenSoldotna$51K
- Stanford DownsAnchorage$19K
- Mary DownsAnchorage$17K
- John KellyWasilla$13K
- Jeffrey SponslerWasilla$8K
- Scot HinesAnchorage$8K
- David HenzlerAnchorage$6K
- Naomi ArensonSoldotna$4K
- Ronald MartinoFairbanks$4K
- Aaron TauerAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.